FHIR IG analytics| Package | de.medizininformatikinitiative.kerndatensatz.molgen |
| Resource Type | Bundle |
| Id | Bundle-mii-exa-befund-bundle-befund-fgfr2-fusion.json |
| FHIR Version | R4 |
No resources found
No resources found
No narrative content found in resource
FHIR
FHIRsmith{
"resourceType": "Bundle",
"id": "mii-exa-befund-bundle-befund-fgfr2-fusion",
"type": "transaction",
"timestamp": "2022-12-16T13:47:00+01:00",
"entry": [
{
"fullUrl": "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-patient-fgfr2-fusion",
"resource": {
"resourceType": "Patient",
"id": "mii-exa-molgen-patient-fgfr2-fusion",
"identifier": [
{
"use": "usual",
"type": {
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v3-ObservationValue",
"code": "PSEUDED"
}
]
},
"system": "https://www.charite.de/fhir/sid/pseudonym",
"value": "3337167192"
}
],
"gender": "female",
"birthDate": "1964-05",
"deceasedBoolean": false,
"address": [
{
"type": "both",
"postalCode": "10",
"country": "DE"
}
]
},
"request": {
"method": "PUT",
"url": "Patient/mii-exa-molgen-patient-fgfr2-fusion"
}
},
{
"fullUrl": "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-practitioner-lab",
"resource": {
"resourceType": "Practitioner",
"id": "mii-exa-molgen-practitioner-lab",
"active": true,
"name": [
{
"use": "official",
"text": "Dr. Daniel Schmidt",
"family": "Schmidt",
"given": [
"Daniel"
],
"prefix": [
"Dr."
]
}
]
},
"request": {
"method": "PUT",
"url": "Practitioner/mii-exa-molgen-practitioner-lab"
}
},
{
"fullUrl": "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-practitioner-physician",
"resource": {
"resourceType": "Practitioner",
"id": "mii-exa-molgen-practitioner-physician",
"active": true,
"name": [
{
"use": "official",
"text": "Dr. Linda Rubens",
"family": "Rubens",
"given": [
"Linda"
],
"prefix": [
"Dr."
]
}
]
},
"request": {
"method": "PUT",
"url": "Practitioner/mii-exa-molgen-practitioner-physician"
}
},
{
"fullUrl": "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-molekulargenetischer-befundbericht-fgfr2-fusion",
"resource": {
"resourceType": "DiagnosticReport",
"id": "mii-exa-molgen-molekulargenetischer-befundbericht-fgfr2-fusion",
"meta": {
"profile": [
"https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/molekulargenetischer-befundbericht|2026.0.4",
"http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/genomic-report|3.0.0"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/recommended-action",
"valueReference": {
"reference": "Task/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion"
}
}
],
"basedOn": [
{
"reference": "ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"
}
],
"status": "final",
"category": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0074",
"code": "GE",
"display": "Genetics"
}
]
}
],
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "51969-4",
"display": "Genetic analysis report"
}
]
},
"subject": {
"reference": "Patient/mii-exa-molgen-patient-fgfr2-fusion"
},
"performer": [
{
"reference": "Practitioner/mii-exa-molgen-practitioner-lab"
}
],
"result": [
{
"reference": "Observation/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion"
},
{
"reference": "Observation/mii-exa-molgen-variante-fgfr2-fusion"
},
{
"reference": "Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"
}
],
"conclusion": "Nachweis FGFR2-Fusion. Empfehlung: Hochselektive FGFR-Inhibitor-Therapie."
},
"request": {
"method": "PUT",
"url": "DiagnosticReport/mii-exa-molgen-molekulargenetischer-befundbericht-fgfr2-fusion"
}
},
{
"fullUrl": "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-anforderung-fgfr2-fusion",
"resource": {
"resourceType": "ServiceRequest",
"id": "mii-exa-molgen-anforderung-fgfr2-fusion",
"meta": {
"profile": [
"https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/anforderung-genetischer-test|2026.0.4"
]
},
"identifier": [
{
"system": "https://www.charite.de/fhir/auftragsnummern",
"value": "PRK4QE59A"
}
],
"status": "active",
"intent": "order",
"category": [
{
"coding": [
{
"system": "http://snomed.info/sct",
"code": "108252007",
"display": "Laboratory procedure (procedure)"
}
]
}
],
"code": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "405825005",
"display": "Molecular genetic test (procedure)"
}
],
"text": "Therapierelevante genetische Veränderungen bei Intrahepatischem Gallengangskarzinom"
},
"subject": {
"reference": "Patient/mii-exa-molgen-patient-fgfr2-fusion"
},
"authoredOn": "2022-11-30",
"requester": {
"reference": "Practitioner/mii-exa-molgen-practitioner-physician"
},
"reasonCode": [
{
"coding": [
{
"system": "http://snomed.info/sct",
"code": "109842005",
"display": "Intrahepatic bile duct carcinoma (disorder)"
},
{
"system": "http://fhir.de/CodeSystem/bfarm/icd-10-gm",
"version": "2024",
"code": "C22.1",
"display": "Intrahepatisches Gallengangskarzinom"
}
]
}
]
},
"request": {
"method": "PUT",
"url": "ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"
}
},
{
"fullUrl": "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-variante-fgfr2-fusion",
"resource": {
"resourceType": "Observation",
"id": "mii-exa-molgen-variante-fgfr2-fusion",
"meta": {
"profile": [
"https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/variante|2026.0.4",
"http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/variant|3.0.0"
]
},
"basedOn": [
{
"reference": "ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"
}
],
"status": "final",
"category": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/observation-category",
"code": "laboratory",
"display": "Laboratory"
}
]
},
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0074",
"code": "GE"
}
]
}
],
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "69548-6",
"display": "Genetic variant assessment"
}
]
},
"subject": {
"reference": "Patient/mii-exa-molgen-patient-fgfr2-fusion"
},
"effectiveDateTime": "2022-11-30",
"valueCodeableConcept": {
"coding": [
{
"system": "http://loinc.org",
"code": "LA9633-4",
"display": "Present"
}
]
},
"method": {
"coding": [
{
"system": "http://loinc.org",
"code": "LA26398-0",
"display": "Sequencing"
},
{
"system": "http://loinc.org",
"code": "86206-0",
"display": "Whole genome sequence analysis in Blood or Tissue by Molecular genetics method"
}
]
},
"component": [
{
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "48018-6"
}
]
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://www.genenames.org/geneId",
"code": "HGNC:3689",
"display": "FGFR2"
}
]
}
},
{
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "48019-4"
}
]
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://sequenceontology.org",
"code": "SO:0001565",
"display": "gene_fusion"
}
]
}
},
{
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "95123-6"
}
]
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://www.genenames.org/geneId",
"code": "HGNC:3689::HGNC:2697",
"display": "FGFR2::DBP"
}
]
}
}
]
},
"request": {
"method": "PUT",
"url": "Observation/mii-exa-molgen-variante-fgfr2-fusion"
}
},
{
"fullUrl": "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion",
"resource": {
"resourceType": "Observation",
"id": "mii-exa-molgen-diagnostische-implikation-fgfr2-fusion",
"meta": {
"profile": [
"https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/diagnostische-implikation|2026.0.4",
"http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/diagnostic-implication|3.0.0"
]
},
"status": "final",
"category": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/observation-category",
"code": "laboratory",
"display": "Laboratory"
}
]
},
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0074",
"code": "GE"
}
]
}
],
"code": {
"coding": [
{
"system": "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
"code": "diagnostic-implication",
"display": "Diagnostic Implication"
}
]
},
"subject": {
"reference": "Patient/mii-exa-molgen-patient-fgfr2-fusion"
},
"effectiveDateTime": "2022-11-30",
"performer": [
{
"reference": "Practitioner/mii-exa-molgen-practitioner-lab"
}
],
"derivedFrom": [
{
"reference": "Observation/mii-exa-molgen-variante-fgfr2-fusion"
}
],
"component": [
{
"code": {
"coding": [
{
"system": "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
"code": "conclusion-string"
}
]
},
"valueString": "starke Überexpression (25-fach)"
}
]
},
"request": {
"method": "PUT",
"url": "Observation/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion"
}
},
{
"fullUrl": "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion",
"resource": {
"resourceType": "Observation",
"id": "mii-exa-molgen-therapeutische-implikation-fgfr2-fusion",
"meta": {
"profile": [
"https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/therapeutische-implikation|2026.0.4",
"http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/therapeutic-implication|3.0.0"
]
},
"status": "final",
"category": [
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/observation-category",
"code": "laboratory",
"display": "Laboratory"
}
]
},
{
"coding": [
{
"system": "http://terminology.hl7.org/CodeSystem/v2-0074",
"code": "GE"
}
]
}
],
"code": {
"coding": [
{
"system": "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
"code": "therapeutic-implication",
"display": "Therapeutic Implication"
}
]
},
"subject": {
"reference": "Patient/mii-exa-molgen-patient-fgfr2-fusion"
},
"effectiveDateTime": "2022-11-30",
"performer": [
{
"reference": "Practitioner/mii-exa-molgen-practitioner-lab"
}
],
"derivedFrom": [
{
"reference": "Observation/mii-exa-molgen-variante-fgfr2-fusion"
}
],
"component": [
{
"code": {
"coding": [
{
"system": "http://hl7.org/fhir/uv/genomics-reporting/CodeSystem/tbd-codes-cs",
"code": "conclusion-string"
}
]
},
"valueString": "Hochselektiver FGFR2-Inhibitor RLY-4008 bei Patienten mit Cholangiokarzinomen und anderen soliden Tumoren, mit oder ohne FGFR- gerichtete Vortherapie."
},
{
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "51963-7",
"display": "Medication assessed [ID]"
}
]
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://www.whocc.no/atc",
"code": "L01EN",
"display": "Fibroblasten-Wachstumsfaktor-Rezeptor (FGFR)-Tyrosinkinase-Inhibitoren"
},
{
"system": "http://snomed.info/sct",
"code": "1162485005",
"display": "Substance with fibroblast growth factor receptor inhibitor mechanism of action (substance)"
}
]
}
},
{
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "93044-6"
}
]
},
"valueCodeableConcept": {
"text": "m1c"
}
},
{
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "81259-4"
}
]
},
"valueCodeableConcept": {
"coding": [
{
"system": "http://snomed.info/sct",
"code": "109842005",
"display": "Intrahepatic bile duct carcinoma (disorder)"
},
{
"system": "http://fhir.de/CodeSystem/bfarm/icd-10-gm",
"version": "2024",
"code": "C22.1",
"display": "Intrahepatisches Gallengangskarzinom"
}
]
}
}
]
},
"request": {
"method": "PUT",
"url": "Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"
}
},
{
"fullUrl": "https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion",
"resource": {
"resourceType": "Task",
"id": "mii-exa-molgen-medikationsempfehlung-fgfr2-fusion",
"meta": {
"profile": [
"https://www.medizininformatik-initiative.de/fhir/ext/modul-molgen/StructureDefinition/medikationsempfehlung|2026.0.4",
"http://hl7.org/fhir/uv/genomics-reporting/StructureDefinition/medication-recommendation|3.0.0"
]
},
"basedOn": [
{
"reference": "ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion"
}
],
"status": "requested",
"intent": "proposal",
"code": {
"coding": [
{
"system": "http://loinc.org",
"code": "LA26421-0",
"display": "Consider alternative medication"
}
],
"text": "Hochselektive FGFR-Inhibitor-Therapie"
},
"for": {
"reference": "Patient/mii-exa-molgen-patient-fgfr2-fusion"
},
"reasonReference": {
"reference": "Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion"
}
},
"request": {
"method": "PUT",
"url": "Task/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion"
}
}
]
}